ask="266.00"
ask_size="300"
average_daily_volume="430733"
bid="16.26"
bid_size="200"
book_value="3.21"
change="-0.53"
change_from_200_day_moving_average="5.16"
change_from_50_day_moving_average="0.03"
change_from_52_week_high="-3.66"
change_From_52_week_low="14.23"
change_in_percent="-2.57%"
close="20.09"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.48"
ex_dividend_date="N/A"
float_shares="7150000"
high="20.64"
high_52_weeks="23.75"
last_trade_date="3/7/2017"
last_trade_price="20.09"
last_trade_size="1962"
last_trade_time="4:00pm"
low="19.69"
low_52_weeks="5.86"
market_capitalization="199.96M"
moving_average_200_day="14.93"
moving_average_50_day="20.06"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.63"
open="20.51"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+34.54%"
percent_change_from_50_day_moving_average="+0.15%"
percent_change_from_52_week_high="-15.41%"
percent_change_from_52_week_low="+242.83%"
previous_close="20.62"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.43"
price_per_sales="3630.86"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.00"
stock_exchange="NGM"
symbol="ZYNE"
volume="381902"
weeks_range_52="5.86 - 23.75"
